Lunai Bioworks Return on Tangible Equity 2013-2025 | LNAI
Current and historical return on tangible equity values for Lunai Bioworks (LNAI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Lunai Bioworks Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $-0.18B | $-0.03B | 734.02% |
| 2025-03-31 | $-0.07B | $-0.02B | 276.29% |
| 2024-12-31 | $-0.13B | $-0.03B | 442.11% |
| 2024-09-30 | $-0.12B | $-0.02B | 501.01% |
| 2024-06-30 | $-0.09B | $-0.03B | 409.20% |
| 2024-03-31 | $-0.10B | $-0.04B | 564.71% |
| 2023-12-31 | $-0.04B | $-0.01B | 482.35% |
| 2023-09-30 | $-0.04B | $-0.01B | 551.72% |
| 2023-06-30 | $-0.04B | $-0.01B | 650.00% |
| 2023-03-31 | $-0.11B | $-0.01B | 2494.12% |
| 2022-12-31 | $-0.11B | $-0.01B | 2880.00% |
| 2022-09-30 | $-0.11B | $0.00B | 4440.00% |
| 2022-06-30 | $-0.11B | $0.00B | 6457.14% |
| 2022-03-31 | $-0.04B | $-0.01B | -8000.00% |
| 2021-12-31 | $-0.04B | $0.00B | -5066.67% |
| 2021-09-30 | $-0.03B | $0.00B | 13600.00% |
| 2021-06-30 | $-0.03B | $0.01B | 3466.67% |
| 2021-03-31 | $-0.01B | $0.00B | 472.73% |
| 2020-12-31 | $-0.01B | $-0.01B | 1466.67% |
| 2020-09-30 | $-0.01B | $0.00B | -571.43% |
| 2020-06-30 | $-0.01B | $0.00B | -320.00% |
| 2020-03-31 | $-0.01B | $0.00B | -127.27% |
| 2019-12-31 | $-0.01B | $0.01B | -800.00% |
| 2019-09-30 | $-0.02B | $0.01B | 733.33% |
| 2019-06-30 | $-0.02B | $0.01B | 276.92% |
| 2019-03-31 | $-0.02B | $-0.01B | 204.88% |
| 2018-12-31 | $-0.02B | $-0.01B | 763.64% |
| 2018-09-30 | $-0.01B | $-0.01B | -1200.00% |
| 2018-06-30 | $-0.01B | $-0.01B | -184.62% |
| 2018-03-31 | $0.00B | $0.02B | -72.73% |
| 2017-12-31 | $0.00B | $0.00B | -100.00% |
| 2017-09-30 | $0.00B | $0.00B | -400.00% |
| 2017-06-30 | $0.00B | $0.00B | 266.67% |
| 2017-03-31 | $0.00B | $0.00B | 240.00% |
| 2016-12-31 | $0.00B | $0.00B | 400.00% |
| 2016-09-30 | $0.00B | $0.00B | 400.00% |
| 2016-06-30 | $0.00B | $0.00B | 0.00% |
| 2016-03-31 | $0.00B | $0.00B | -400.00% |
| 2015-09-30 | $0.00B | $0.00B | 400.00% |
| 2015-03-31 | $0.00B | 133.33% | |
| 2014-09-30 | $0.00B | $0.00B | 50.00% |
| 2014-06-30 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.024B | $0.000B |
| Lunai Bioworks Inc. is an AI-powered drug discovery and biodefense company. Lunai Bioworks Inc., formerly known as RENOVARO INC, is based in LOS ANGELES. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.812B | 58.34 |
| Tempus AI (TEM) | United States | $11.803B | 0.00 |
| Doximity (DOCS) | United States | $9.361B | 38.54 |
| Hims & Hers Health (HIMS) | United States | $8.207B | 66.76 |
| IRhythm Technologies (IRTC) | United States | $5.429B | 0.00 |
| Hinge Health (HNGE) | United States | $3.287B | 0.00 |
| Privia Health (PRVA) | United States | $2.921B | 182.69 |
| Heartflow (HTFL) | United States | $2.635B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.522B | 41.72 |
| 10x Genomics (TXG) | United States | $2.035B | 0.00 |
| Enovis (ENOV) | United States | $1.765B | 9.27 |
| Omnicell (OMCL) | United States | $1.596B | 32.62 |
| Azenta (AZTA) | United States | $1.370B | 59.76 |
| Phreesia (PHR) | United States | $1.350B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Schrodinger (SDGR) | United States | $1.267B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.915B | 0.00 |
| Claritev (CTEV) | United States | $0.730B | 0.00 |
| Talkspace (TALK) | United States | $0.535B | 107.67 |
| Veradigm (MDRX) | United States | $0.534B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.523B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Standard BioTools (LAB) | United States | $0.461B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.365B | 0.00 |
| Carlsmed (CARL) | United States | $0.338B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.08 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.296B | 0.00 |
| CapsoVision (CV) | United States | $0.265B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.225B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.202B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.188B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.181B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.166B | 0.00 |
| CareCloud (CCLD) | United States | $0.135B | 7.40 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| Outset Medical (OM) | United States | $0.089B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.076B | 0.00 |
| Pulmonx (LUNG) | United States | $0.066B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.036B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |